Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Solventum Corporation, DexCom or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Solventum Corporation, DexCom and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Solventum Corporation, DexCom and Inc.

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Latest Health Care Equipment & Supplies and Solventum Corporation, DexCom, Inc. Stock News

As of March 27, 2026, Solventum Corporation had a $10.9 billion market capitalization, compared to the Health Care Equipment & Supplies median of $280.1 million. Solventum Corporation’s stock is down 19.6% in 2026, down 3% in the previous five trading days and down 15.46% in the past year.

Currently, Solventum Corporation’s price-earnings ratio is 7.1. Solventum Corporation’s trailing 12-month revenue is $8.3 billion with a 18.7% net profit margin. Year-over-year quarterly sales growth most recently was -3.7%. Analysts expect adjusted earnings to reach $6.464 per share for the current fiscal year. Solventum Corporation does not currently pay a dividend.

As of March 27, 2026, DexCom, Inc. had a $24.0 billion market cap, putting it in the 88th percentile of all stocks. DexCom, Inc.’s stock is down 5.5% in 2026, down 4.9% in the previous five trading days and down 13.7% in the past year.

Currently, DexCom, Inc.’s price-earnings ratio is 29.8. DexCom, Inc.’s trailing 12-month revenue is $4.7 billion with a 17.9% net profit margin. Year-over-year quarterly sales growth most recently was 13.1%. Analysts expect adjusted earnings to reach $2.494 per share for the current fiscal year. DexCom, Inc. does not currently pay a dividend.

How We Compare Solventum Corporation, DexCom and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Solventum Corporation, DexCom and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Solventum Corporation, DexCom and Inc. Stock Value Grades

Company	Ticker	Value
Solventum Corporation	SOLV	C
DexCom, Inc.	DXCM	F

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection.

Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Value Grade derives from a stock’s value score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.

Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are a good value and so on.

Solventum Corporation has a Value Score of 58, which is Average. DexCom, Inc. has a Value Score of 18, which is Ultra Expensive.

The Value Stock Winner: No Clear Winner

Neither Solventum Corporation, DexCom or Inc. has a high enough value grade to be considered a “winner.” Investors who are considering these companies should do additional due diligence and research to see if either could be a good addition to their portfolio. It’s important to look at a wide range of financial metrics in order to determine if Solventum Corporation, DexCom or Inc. is the better investment when it comes to value.

Solventum Corporation, DexCom and Inc.’s Quality Grades

Company	Ticker	Quality
Solventum Corporation	SOLV	B
DexCom, Inc.	DXCM	A

Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.

The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.

The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.

Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.

Solventum Corporation has a Quality Score of 70, which is Strong. DexCom, Inc. has a Quality Score of 99, which is Very Strong.

The Quality Grade Winner: DexCom, Inc.

As you can clearly see from the Quality Grade breakdown above, DexCom, Inc. has a better overall quality grade than Solventum Corporation. For investors who are looking for companies with higher quality than others in the same industry, DexCom, Inc. could be a good stock to add to their portfolios. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Solventum Corporation, DexCom and Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Solventum Corporation	SOLV	B
DexCom, Inc.	DXCM	C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Solventum Corporation has a Earnings Estimate Score of 77, which is Positive. DexCom, Inc. has a Earnings Estimate Score of 49, which is Neutral.

The Earnings Estimate Revisions Grade Winner: Solventum Corporation

As you can clearly see from the Earnings Estimate Revisions Grade breakdown above, Solventum Corporation has a better Earnings Estimate Revisions Grade than DexCom, Inc.. For those who are specifically looking for companies with better short-term prospects when compared to other companies in the same industry, Solventum Corporation could be a good stock to invest in. However, it’s important to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other Solventum Corporation, DexCom and Inc. Grades

In addition to Value, Quality and Estimate Revisions, A+ Investor also provides grades for Growth and Momentum.

Momentum grades help uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming.

Growth investing builds on the idea that stocks of companies exhibiting strong, consistent and prolonged growth outperform those of slower-growth companies. AAII measures growth through consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Solventum Corporation, DexCom and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Solventum Corporation, DexCom or Inc. Stock?

Overall, Solventum Corporation stock has a Value Score of 58, Estimate Revisions Score of 77 and Quality Score of 70.

DexCom, Inc. stock has a Value Score of 18, Estimate Revisions Score of 49 and Quality Score of 99.

Comparing Solventum Corporation, DexCom and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.